Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The American Journal of Gastroenterology|October 1, 1994
Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitisV P Kodali, S C Gordon, A L Silverman, et al.
American Journal of Clinical Pathology|December 31, 1997
Comparative histologic features of liver biopsy specimens from patients coinfected with hepatitis G and C viruses with chronic hepatitis C virus alone: an age-, sex-, disease duration-, and transmission-matched controlled study of chronic hepatitisN S Goldstein, J Underhill, S C Gordon, et al.
Hepatology (Baltimore, Md.)|December 1, 1993
The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug useS C Gordon, R S Elloway, J C Long, et al.
Medical and Veterinary Entomology|December 23, 1999
The spatial distribution of larvae of Culicoides impunctatus biting midgesA Blackwell, K A Lock, B Marshall, et al.
Viral Immunology|February 24, 2001
Immunological responses in patients who have spontaneously eradicated hepatitis C virus infectionI M Zitron, M Laurinaitis, L Qu, et al.
Eye (London, England)|January 26, 2008
A survey of investigations used for the management of glaucoma in hospital service in the United KingdomP S C Gordon-Bennett, A S Ioannidis, K Papageorgiou, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2014
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infectionS Saab, S C Gordon, H Park, et al.
American Journal of Clinical Pathology|February 1, 1992
A flow cytometric method to detect anti-pyruvate dehydrogenase antibody in primary biliary cirrhosisM Y Elkhalifa, F L Kiechle, S C Gordon, et al.
Southern Medical Journal|December 1, 1986
Resection of metachronous hepatocellular carcinomasS C Gordon, K R Reddy, R Zeppa, et al.
Alimentary Pharmacology & Therapeutics|January 27, 2015
Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infectionZ M Younossi, H Park, S Saab, et al.
Pageof 8